PN 79036
RN 01016 
AN 79122941
AU Harries-J-T.  Muller-D-P.  McCollum-J-P.  Lipson-A.  Roma-E.
   Norman-A-P.
TI Intestinal bile salts in cystic fibrosis: studies in the patient and
   experimental animal.
SO Arch-Dis-Child. 1979 Jan. 54(1). P 19-24.
MJ BILE-ACIDS-AND-SALTS: me.  CYSTIC-FIBROSIS: me.  DUODENUM: me.
   INTESTINAL-SECRETIONS: me.
MN ADOLESCENCE.  ANIMAL.  CHILD.  CHILD-PRESCHOOL.
   ENTEROHEPATIC-CIRCULATION.  FEMALE.  HUMAN.  ILEUM: me.  INFANT.
   INTESTINAL-ABSORPTION: de.  MALE.  RATS.  RICINOLEIC-ACIDS: pd.
   SERUM-ALBUMIN-BOVINE: pd.  TAUROCHOLIC-ACID: me.  TRIOLEIN: pd.
AB The quantitative and qualitative distribution of bile salts in the
   duodenal juice of 13 patients with cystic fibrosis (CF) was studied
   after a test meal. The effects of triolein (TO), bovine serum albumin
   (BSA), and ricinoleic acid (RA) on the absorption of taurocholate
   (TCA) in the distal ileum of the rat in vivo was also studied. The
   mean (and ranges) of total bile salt concentrations, glycine: taurine
   conjugate ratios, and percentage of dihydroxy bile salts in the
   patients with CF and pancreatic insufficiency were 3.5 (1.3--6.6)
   mmol/l, 8.6 (greater than 10-3.1), and 37 (10--60) compared with
   control values of 7.4 (3.0--16.0) mmol/l, 3.0 (1.3--4.5), and 61 (52--
   70) respectively. The differences between the control and CF values
   were statistically significant (P less than 0.01--P less than 0.001).
   Three of the 13 CF patients had total bile salt concentrations less
   than 2 mmol/l, 8 had much higher glycine: taurine ratios, and 8 had a
   reduced percentage of dihydroxy bile salts. In 2 patients with normal
   pancreatic enzyme activities, duodenal bile salts were both
   quantitatively and qualitatively normal. TO (10 and 30 mmol/l), BSA
   (3%), and RA (5 mmol/l) had no inhibitory effect on the ileal
   absorption of TCA. These results show pronounced abnormalities of
   duodenal juice bile salts in CF with pancreatic insufficiency
   consistent with a broken enterohepatic circulation (EHC); such
   abnormalities may contribute to defective lipid absorption in CF. The
   data in the experimental animal do not support the suggestion that
   unhydrolysed dietary substrates play a role in the pathophysiology of
   the broken EHC.
RF 001   ANTONOWICZ I          PEDIATRICS                      42   492 968
   002   DAWSON AM             PROC SOC EXP BIOL MED          142   906 973
   003   DEREN JJ              N ENGL J MED                   288   949 973
   004   DOWLING RH            GASTROENTEROLOGY                62   122 972
   005   FREYE HB              J PEDIATR                       64   575 964
   006   GIBBONS ISE           IN: LAWSON D PROC 5TH INT CF         279 969
   007   GOODCHILD MC          ARCH DIS CHILD                  50   769 975
   008   HARRIES JT            GUT                             13   596 972
   009   HEATON KW             BILE SALTS IN HEALTH AND DISE            972
   010   HOFMANN AF            IN: JAMES AT                         362 964
   011   IWATA T               J BIOCHEM (TOKYO)               56   424 964
   012   MCCOLLUM JPK          ARCH DIS CHILD                  52   887 977
   013   MAKINO I              ANAL LETT                        5   341 972
   014   MATTHEWS DM           GUT                              6   411 965
   015   MORIN CL              J PEDIATR                       88   213 976
   016   POLEY JR              J LAB CLIN MED                  63   838 964
   017   ROLLER RJ             GASTROENTEROLOGY                72   661 977
   018   ROY CC                N ENGL J MED                   297  1301 977
   019   SLADEN GE             BIOCHIM BIOPHYS ACTA           288   443 972
   020   THOMAIDIS TS          J PEDIATR                       63   444 963
   021   TOSKES PP             J CLIN INVEST                   52  1660 973
   022   WATKINS JB            GASTROENTEROLOGY                67   835 974
   023   WATKINS JB            GASTROENTEROLOGY                73  1023 977
   024   WEBER AM              N ENGL J MED                   289  1001 973
   025   WEBER AM              GUT                             17   295 976
CT   1   FREDRIKZON B          PEDIATR RES                     14  1387 980
     2   GORIUP U              HELV PAEDIATR ACTA              35   177 980
     3   BALISTRERI WF         J PEDIATR                       96   582 980
     4   ELIAS E               LANCET                           2  1319 981
     5   FONDACARO JD          PROC SOC EXP BIOL MED          168   276 981
     6   ROY CC                J PEDIATR GASTROENTEROL NUTR     1   469 982
     7   MULLER DPR            CLIN GASTROENTEROL              11   119 982
     8   STAFFORD RJ           CLIN GASTROENTEROL              11   141 982
     9   HEUBI JE              GASTROENTEROLOGY                83   804 982
    10   FREDRIKZON B          ACTA PAEDIATR SCAND SUPPL 296 1982    75 982
    11   BALISTRERI WF         J PEDIATR GASTROENTEROL NUTR     2   105 983
    12   ISENBERG JN           J PEDIATR GASTROENTEROL NUTR     2   447 983
    13   ROY CC                J PEDIATR GASTROENTEROL NUTR     2   152 983
    14   FONDACARO JD          PROC SOC EXP BIOL MED          173   118 983
    15   COLOMBO C             J PEDIATR GASTROENTEROL NUTR     3   556 984
    16   TAZAWA Y              J PEDIATR GASTROENTEROL NUTR     3   378 984
    17   ZENTLERMUNRO PL       GUT                             25   500 984
    18   ABRAMS CK             J CLIN INVEST                   73   374 984
    19   MCKENNA MC            J PEDIATR GASTROENTEROL NUTR     4    45 985
    20   DARLING PB            PEDIATR RES                     19   578 985
    21   ROBB TA               GUT                             26  1246 985
    22   SETCHELL KDR          CLIN CHIM ACTA                 151   101 985
    23   WEBER AM              ACTA PAEDIATR SCAND SUPPL 317 1985     9 985
    24   WEIZMAN Z             GUT                             27  1043 986
    25   LEROY C               DIG DIS SCI                     31   911 986
    26   DUTTA SK              GASTROENTEROLOGY                91  1243 986